// App-Quantinova.ai

: Effect of dupilumab on severe exacerbations and lung function in patients with baseline blood eosinophils =500 cells/µL

Researchers

Presenter

  • Klaus F. Rabe

Principal Investigators

  • Ian D. Pavord

  • Mario Castro

  • Nadia Daizadeh

  • Benjamin Ortiz

  • Robert Johnson

  • Yamo Deniz

  • Paul Rowe

Medical Centers

  • LungenClinic Grosshansdorf, German Center for Lung Research, Grosshansdorf, Germany

  • University of Oxford, Oxford, United Kingdom

  • University of Kansas School of Medicine, Kansas City, MO

  • Regeneron Pharmaceuticals - Tarrytown - United States of America

  • Sanofi US, Bridgewater, United States of America

Locations

  • Germany

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Dupilumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT02414854

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved